SAI
GILD icon

Systematic Alpha Investments’s Gilead Sciences GILD Stock Holding History

Systematic Alpha Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-100
Closed -$6K – 326
2021
Q3 		$6K Hold
100
– – ﹤0.01% 436
2021
Q2 		$7K Hold
100
– – ﹤0.01% 291
2021
Q1 		$6K Sell
100
-44,000
-100% -$2.84M ﹤0.01% 219
2020
Q4 		$2.57M Buy
+44,100
New +$2.66M 0.28% 62

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Systematic Alpha Investments's GILD Position: Q4 2021 in Review

Systematic Alpha Investments sold out of Gilead Sciences (GILD) in Q4 2021, closing a stake of 100 shares — an estimated $6K sold.

Systematic Alpha Investments first reported a position in GILD in Q4 2020 and held it in 4 quarters. The position peaked at $2.57M in Q4 2020. 1,683 funds tracked by Wall St. Rank hold GILD as of Q4 2021.

  • Systematic Alpha Investments reported no remaining Gilead Sciences position as of Q4 2021 after selling out during the quarter.
  • Systematic Alpha Investments sold 100 Gilead Sciences shares in Q4 2021, an estimated $6K.
  • Systematic Alpha Investments first reported a position in Gilead Sciences in Q4 2020 and held it in 4 quarters.
  • Systematic Alpha Investments's Gilead Sciences position peaked at $2.57M in Q4 2020.
  • 1,683 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.

Based on Systematic Alpha Investments's 13F filing for Q4 2021, filed 15 Feb 2022.